SCHEMBL257111

SCHEMBL257111

CCc1ccc(SC(F)(F)F)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRZ1 P23471 4/20 0.61
PTPN1 P18031 2/20 0.61
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
EPHX2 P34913 1/20 0.44
NR1H4 Q96RI1 1/20 0.44
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.38
ATM Q13315 1/20 0.38
TAAR1 Q96RJ0 1/20 0.38
LMNA P02545 2/20 0.38
MBOAT4 Q96T53 1/20 0.38
SLC6A4 P31645 1/20 0.37
ALKBH5 Q6P6C2 1/20 0.37
FTO Q9C0B1 1/20 0.37
KIF11 P52732 1/20 0.37
HTT P42858 1/20 0.37
CYP2A6 P11509 1/20 0.37
LPL P06858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22111434 0.84 PTPRZ1 (0.44) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL13064734 0.83 PTPRZ1 (0.57) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL18998006 0.81 PTPRZ1 (0.65) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL6001747 0.81 PTPRZ1 (0.65) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL27597569 0.79 PTPRZ1 (0.53) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL13020828 0.78 PTPRZ1 (0.57) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL27583454 0.78 PTPRZ1 (0.52) PTPRZ1PTPN1KDM4EALDH1A1TDP1
Ethylbenzene SCHEMBL27815944 0.78 PTPRZ1 (0.47) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL95318 0.77 PTPRZ1 (0.61) PTPRZ1PTPN1KDM4EALDH1A1TDP1
SCHEMBL712441 0.77 PTPRZ1 (0.61) PTPRZ1PTPN1KDM4EALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894410-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2023-10-11 EP disclosed
EP-3894409-B1 SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INT (DE) 2023-08-23 EP disclosed
US-20230157287-A1 PESTICIDAL COMPOUNDS BASF SE (DE) 2023-05-25 US disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 WO disclosed
US-20220177479-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-06-09 US disclosed
US-20210395243-A1 PESTICIDAL COMPOUNDS BASF SE (DE) 2021-12-23 US disclosed
EP-3452464-B1 PYRAZOLE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USE THEREOF HOFFMANN LA ROCHE (CH) 2021-12-15 EP disclosed
US-11198696-B2 Substituted xanthines as inhibitors of transient receptor potential cation channel subfamily c, member 5 activity BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2021-12-14 US disclosed
US-11160280-B2 Pesticial compounds BASF SE (DE) 2021-11-02 US disclosed
US-20200352931-A1 OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE Phenex Discovery Verwaltungs-GmbH (DE) 2020-11-12 US disclosed
WO-2008157179-A2 N-SUBSTITUTED AZAINDOLES AND METHODS OF USE GENENTECH, INC. (US) 2008-12-24 WO disclosed
US-20080312435-A1 Imine Compound TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-18 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20080085894-A1 ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2008-04-10 US disclosed
US-20080009543-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2008-01-10 US disclosed
US-20080009543-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2008-01-10 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed
US-7169890-B2 Process for the production of ramoplanin-like amide derivatives VICURON PHARMACEUTICALS INC. (US) 2007-01-30 US disclosed
US-20050159469-A1 HIV protease inhibiting compounds ABBVIE INC. 2005-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 PTPRZ1 3332/4885PTPN1 3756/4885KDM4E 574/4885
US-20080009543-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION CNR1, CNR2, GPR18 PTPRZ1 1357/4885PTPN1 1404/4885KDM4E 310/4885
US-20200352931-A1 OXALAMIDES AS MODULATORS OF INDOLEAMINE 2,3-DIOXYGENASE IDO1, IDO2, INMT PTPRZ1 1433/4885PTPN1 1172/4885KDM4E 1379/4885
US-20080312435-A1 Imine Compound CNR1, CNR2, HRH4 PTPRZ1 4491/4885PTPN1 3506/4885KDM4E 3386/4885
US-11160280-B2 Pesticial compounds PNMT, DDT, NIT2 PTPRZ1 1178/4885PTPN1 2549/4885KDM4E 3421/4885
US-20080085894-A1 ALPHA-(N-SULFONAMIDO)ACETAMIDE DERIVATIVES AS BETA-AMYLOID INHIBITORS APP, APBA1, BACE1 PTPRZ1 2601/4885PTPN1 2775/4885KDM4E 4714/4885
US-20230157287-A1 PESTICIDAL COMPOUNDS PNMT, CAT, DDT PTPRZ1 1440/4885PTPN1 2807/4885KDM4E 4007/4885
US-11198696-B2 Substituted xanthines as inhibitors of transient receptor potential cation channel subfamily c, member 5 activity TRPC5, TRPM5, TRPC4 PTPRZ1 3111/4885PTPN1 2247/4885KDM4E 3188/4885
US-20050159469-A1 HIV protease inhibiting compounds SERPINB1, HPN, DNPEP PTPRZ1 3594/4885PTPN1 3664/4885KDM4E 3048/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 PTPRZ1 3332/4885PTPN1 3756/4885KDM4E 574/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 PTPRZ1 3332/4885PTPN1 3756/4885KDM4E 574/4885
US-20210395243-A1 PESTICIDAL COMPOUNDS NIT2, PNMT, DDT PTPRZ1 1382/4885PTPN1 2750/4885KDM4E 3570/4885
US-20220177479-A1 NOVEL SUBSTITUTED XANTHINE DERIVATIVES TRPC5, TRPC4, TRPM5 PTPRZ1 4303/4885PTPN1 3194/4885KDM4E 3837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.